Old — News — Vivaldi Biosciences

Posts in Old

Universal Influenza Vaccine Company Vivaldi Biosciences and Blue Sky Vaccines Form Agreement on High Growth Influenza Strain Technology − Vivaldi’s DeltaFLU Addresses Goals of President’s Executive Order on Modernizing Influenza Vacci

OldCarrie WickOctober 13, 2019

Universal Influenza Vaccine Company Vivaldi Biosciences Forms Agreement with BlueSky Vaccines for Virus Purification Technologies FORT COLLINS, Colorado and VIENNA, Austria – July 18, 2019 − Vivaldi Biosciences Inc., a clinical-stage c

OldCarrie WickJuly 18, 2019

DeltaFLU pandemic influenza vaccine shows superior antibody response in clinical trial  − Results Published in the Journal Vaccine − FORT COLLINS, Colorado and VIENNA, Austria – June 19, 2019 -- Vivaldi Biosciences, a clinical-

OldCarrie WickJune 18, 2019

Real-time stability testing of DeltaFLU shows no titer loss after 2 years in storage Influenza pandemic preparedness requires rapid availability of hundreds of millions of doses of an appropriate and effective vaccine. Strategies for p

OldYoy Design AgencyMay 17, 2019

Vivaldi presents data at World Vaccine Congress demonstrating potential of DeltaFLU as universal influenza vaccine – DeltaFLU Outperformed Licensed Vaccine Against Drifted and Shifted Influenza Strains – FORT COLLINS, Colorado – April

OldYoy Design AgencyMay 17, 2019

Vivaldi Biosciences’ Phase 2 Influenza Vaccine Shows Broad Cross-Protection and Superiority in Nonclinical Study FORT COLLINS, Colorado – February 12, 2018 − Vivaldi Biosciences, based at the Research Innovation Center at Colorado Stat

OldYoy Design AgencyMay 17, 2019

Vivaldi Biosciences Board Appoints William Wick as Chief Executive Officer and John Costantino as Chairman Fort Collins, CO – May 22, 2017 - Vivaldi Biosciences Inc., a clinical-stage biotechnology company developing genetically attenu

OldYoy Design AgencyMay 17, 2019

Vivaldi Biosciences Appoints Manfred Reiter, PhD as Senior Vice President, Manufacturing Fort Collins, CO – April 28, 2017- Vivaldi Biosciences Inc., a clinical-stage biotechnology company developing genetically attenuated live influen

OldYoy Design AgencyMay 17, 2019